BlackRock Investment Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $751K | Sell |
59,959
-135
| -0.2% | -$1.69K | ﹤0.01% | 2850 |
|
|
2016
Q3 | $832K | Sell |
60,094
-140
| -0.2% | -$1.94K | ﹤0.01% | 2768 |
|
|
2016
Q2 | $595K | Buy |
60,234
+15,056
| +33% | +$149K | ﹤0.01% | 2955 |
|
|
2016
Q1 | $764K | Buy |
45,178
+1,005
| +2% | +$17K | ﹤0.01% | 2659 |
|
|
2015
Q4 | $983K | Buy |
44,173
+285
| +0.6% | +$6.34K | ﹤0.01% | 2614 |
|
|
2015
Q3 | $1.04M | Sell |
43,888
-683
| -2% | -$16.1K | ﹤0.01% | 2570 |
|
|
2015
Q2 | $3.64M | Buy |
44,571
+25,103
| +129% | +$2.05M | ﹤0.01% | 1747 |
|
|
2015
Q1 | $1.8M | Buy |
19,468
+2,362
| +14% | +$219K | ﹤0.01% | 2100 |
|
|
2014
Q4 | $692K | Buy |
17,106
+3,783
| +28% | +$153K | ﹤0.01% | 2805 |
|
|
2014
Q3 | $326K | Sell |
13,323
-124
| -0.9% | -$3.03K | ﹤0.01% | 3141 |
|
|
2014
Q2 | $213K | Buy |
13,447
+69
| +0.5% | +$1.09K | ﹤0.01% | 3214 |
|
|
2014
Q1 | $202K | Buy |
13,378
+958
| +8% | +$14.5K | ﹤0.01% | 3210 |
|
|
2013
Q4 | $171K | Buy |
12,420
+756
| +6% | +$10.4K | ﹤0.01% | 3217 |
|
|
2013
Q3 | $220K | Buy |
+11,664
| New | +$220K | ﹤0.01% | 3158 |
|